Vertebrate splicing factors are localized to discrete domains within the nuclei of somatic cells. The mechanism whereby such nuclear domains, identified as speckles by immunofluorescence microscopy, are generated is unclear. Recent studies suggest that the spatial order within the nucleus is maintained by nuclear matrix factors. Here we show that a protein in the nuclear matrix and mitotic apparatus [nuclearmitotic apparatus protein, NuMA; Lydersen, B. & Pettijohn, D. (1980) Cell 22, 489-499] colocalizes with splicing factors in interphase nuclei and is associated with small nuclear ribonucleoproteins in a complex immunoprecipitated from HeLa extract with small nuclear ribonucleoprotein antibodies. Moreover, NuMA associates with splicing complexes that are reconstituted in vitro using wild-type pre-mRNA, but not with nonspecific RNA. Cumulatively, these observations suggest a function of NuMA or NuMA-like proteins in interphase cells in providing a bridge between RNA processing and the nucleoskeleton.
native splicing (23) , although no correlation has been made between the isoforms and multiple functions for NuMA. In mitotic cells, NuMA appears to play a role in spindle microtubule formation and post-mitotic nuclear assembly as shown by various studies on microtubule inhibition, antibody injection, and expression of truncated NuMA proteins (18) (19) (20) (24) (25) (26) (27) . Beyond its identity as a nuclear matrix protein (17, 19) , however, little is known of the function of NuMA in the interphase nucleus.
Here we investigate the role of NuMA in interphase nuclei by the ability of NuMA-specific antibodies to stain discrete foci and to immunoprecipitate nuclear assemblies. Specifically, we show that NuMA colocalized with the small nuclear ribonucleoprotein particles (snRNPs) required for processing of pre-mRNAs in interphase. Furthermore, we show that NuMA associates in vitro with both nuclear snRNPs and reconstituted spliceosomes.
The eukaryotic nucleus is a highly organized structure. Electron microscopy has provided excellent morphological evidence for the existence ofa complex nucleoskeleton (1, 2) . An intermediate filament-like nuclear network termed core filaments has been revealed by a sequential extraction procedure (2, 3) . These 9-to 13-nm filaments may be the core structure to which other proteins associate to form the nuclear matrix. Many nuclear activities, such as synthesis of DNA and RNA and RNA splicing, have been localized in discrete nuclear domains rather than diffusely distributed throughout the nucleoplasm (4) (5) (6) (7) . Particularly, the localizations of these specific domains persist after the removal of chromatin, indicating that the nuclear matrix has a key function in maintaining spatial order within the nucleus. Recent microscopic studies have suggested that pre-mRNAs are both processed and transported in discrete nuclear "tracks" that might correspond to nuclear filaments (8) (9) (10) (11) . In addition, earlier experiments revealed a preferential association of pre-mRNA with the nuclear matrix (12) (13) (14) (15) (16) . Strong evidence for the relationship of the nucleoskeleton to gene expression, however, has been lacking due to the phenomenological nature of biochemical matrix preparations. No studies have used reagents directed against a well-characterized element of the nucleoskeleton in an attempt to bridge the gap between nuclear architecture and gene expression.
Nuclear-mitotic apparatus protein (NuMA) (17) , also known as centrophilin (18) , SPN (19) , and SP-H (20) , is a 230-kDa nuclear protein that resides at the spindle poles during mitosis. Studies on the primary structure of NuMA have shown that it is a long coiled-coil protein with two globular end domains separated by a discontinuous a-helix (21, 22 In Situ Sequential Extraction. CaSki cells were chosen for core filament preparation (2) because these cells adhere tightly to coverslips after each of the extraction steps. Cells on coverslips were lysed for 2 min in cytoskeleton (CSK) buffer (10 mM Pipes, pH 7.0/100 mM NaCl/300 mM sucrose/3 mM MgCl2/1 mM EGTA/4 mM vanadyl ribonucleoside complex) containing 0.5% Triton X-100 and multiple protease inhibitors [PLAP: 0.1 mM phenylmethylsulfonyl fluoride/leupeptin (1 ,ug/ml)/antipain ( After incubation on ice for 1 hr, 20 ,l/ of protein G-agarose was added to the Y12 immunoprecipitation and agitated on a rocker at 4°C for 1 hr. For agarose-bead-conjugated antibodies, each mixture was gently agitated for 2 hr. Samples were then centrifuged and rinsed three times with PBS containing 0.25 M NaCl and twice with PBS. Pellets were subjected to SDS/PAGE and autoradiography. For samples also used for immunoblots after precipitation, nonlabeled 0.5 M salt HeLa extract was prepared. aTMG antibody (30 /l) coupled to agarose, uncoupled protein G-agarose, or 2 /4 of CREST antibody (32) was used to perform immunoprecipitation as described above and the complexes were examined by SDS/ PAGE and immunoblot analysis using P9 or CREST antibodies.
Immunoprecipitation with in Vitro-Reconstituted Spliceosomes. 32P-labeled splicing precursor RNA was transcribed in vitro from the MINX adenovirus minigene containing a single intron (16) . Precursor RNA was capped during synthesis. HeLa nuclear extract was prepared as described (33) and in vitro splicing was performed as reported (34) . All antibodies were affinity-purified from cell culture medium, ascites fluid, or serum. Purified antibodies at concentrations of 3-5 ug were added to each reaction mixture and incubated on ice for 15 min. To precipitate the immunocomplexes, we found that the prewashed streptococcal protein G was much more effective than agarose-conjugated protein G. After incubation with 20 ul of protein G for 15 min on ice, pellets were washed with modified NETS (50 mM Tris-HCl, pH 7.9/150 mM NaCl/0.05% Nonidet P-40/1.5 mM MgCl2/0.5 mM dithiothreitol). After ethanol precipitation, RNA was dissolved in 90% (vol/vol) formamide/10 mM EDTA, boiled, and resolved on a 10%6 polyacrylamide gel containing 9 M urea.
RESULTS AND DISCUSSIONS Colocalization of NuMA and snRNPs. To obtain reagents specific for NuMA, a monoclonal antibody (2D3) specific for primate NuMA (18) was used to screen a cDNA library prepared from the human cell line HT29. A partial cDNA of 1.9 kb was isolated and determined to code for NuMA by sequence analysis (21, 22 (17) . The middle band, detected only with the polyclonal antibody, was a known isoform of NuMA produced by alternative splicing (23) as determined by peptide digestion (35) (data not shown). The 160-kDa protein recognized by all three antibodies had a different protein digestion pattern than the largest bands and, therefore, probably represents a protein other than NuMA containing a common epitope.
Although all three antibodies exhibited identical staining of spindle poles in metaphase, two distinct patterns of staining were observed for interphase nuclei (Fig. 2) (Fig. 1) , the different fluorescent pattern ofthe two antibodies is probably due to differential availability of each epitope of NuMA ( Fig.  2 a and b) . This difference in staining suggests that the epitope recognized by 8.22 antibody resides in a particular nuclear domain distinct from those containing the majority of the NuMA protein. The foci produced by 8.22 were reminiscent of the staining patterns of a number of splicing factors. To further investigate this similarity, cells were stained withboth 8.22 and an aSm antibody that reacts with human snRNPs (28) (Fig. 2 c-h ). In interphase nuclei, the two staining patterns colocalized with the exception that aSm, but not 8.22, also stained a few distinct spots presumed to be coiled bodies (coilin-containing nuclear foci of unknown function) (36) (37) (38) (Fig. 2 c-e) . During mitosis, however, the staining (b) generated interphase patterns of diffuse nuclear staining or nuclear foci and speckles, respectively; and mitotic patterns of spindle crescents. P9 gave the same staining pattern as 2D3 (data not shown). (c-4) Nuclear staining of human cervical epidermoid carcinoma cells (CaSki) with 8.22 produced smaller and more numerous nuclear foci and speckles than HeLa cells. (c-h) Computerized pseudocolor of double immunofluorescence with 8.22 (c and f) (green) and human aSm antibody (d and g) (red). The patterns produced by the two antibodies in interphase nuclei are superimposable (e) (yellow). The only exception is the specific staining of one to a few round spots presumed to be coiled bodies (36-38) (arrows, and red in e) by aSm, but not 8.22. (f-h) Mitotic staining by the same procedure with the majority of 8. 22 antibody deposited in the polar regions. Most aSm assumed a diffuse localization in the cytoplasm. (i andj) Staining of the nuclear core filament system prepared by DNA digestion and gradient salt extraction (2) with the aNuMA (i) and aSm (j) still colocalized and yielding higher intensity and more foci and speckles, implying more antigens were uncovered by extraction. (k and l) Staining of the core filaments after the preparations in i and j, respectively, were treated with RNase A. Treatment deformed the speckles to blobs but colocalization remained. pattern ofthe two antibodies differed considerably. As shown in Fig. 2 f-h, 8.22 antibody transferred to the polar regions, whereas the aSm antibody assumed a diffuse localization in the cytoplasm. Both NuMA and aSm antigens reappeared in the newly formed daughter nuclei at late telophase. The coalescence of snRNP-specific and NuMA-specific antibodies only during interphase indicates that the antibodies are recognizing two distinct epitopes that both occupy a nuclear domain during only one portion of the cell cycle.
In a separate immunoelectron microscopy study, we found NuMA to be a component of core filaments, the skeleton of the nuclear matrix consisting of heterogeneous proteins and RNAs (2) . To further document the colocalization of NuMA and snRNPs, core filaments were prepared by DNA digestion and gradient salt extraction (Fig. 2 i andj) . A portion of this material was treated further with RNase A (Fig. 2 k and 1) . The two antigens remained colocalized after both treatments, despite the changes each treatment caused to nuclear structure. After DNase I and salt treatment, both antigens retained the same pattern as the control except for more intensive staining. After RNase treatment, which disrupted the core filament system, the speckled pattern was replaced by large patches. These shown). The 160-kDa protein, therefore, may not exist in core filaments. NuMA Associates with snNP. To address further whether NuMA antigens are stably associated with snRNPs, we asked whether we could detect NuMA in preparations of snRNPs that had been immunoprecipitated from nuclear extracts with either the aSm antibody or with an antibody (aTMG) specific for the trimethylguanosine cap associated with snRNAs (31) (Fig. 3) . The aSm, aTMG, 2D3, and 8.22 antibodies all immunoprecipitated a doublet of .200 kDa from nuclear extracts of HeLa cells that had been labeled with [35S]methionine (Fig. 3 a and b) . Immunoblot analysis of the aTMG immunoprecipitate with the polyclonal NuMA antibody P9 indicated that this large doublet was indeed related to NuMA (Fig. 3c) . As controls, a centromere/kinetochore-specific CREST antibody (32) could neither precipitate NuMA (Fig.  3c, lane 2) nor detect CREST antigens in a aTMG precipitate (Fig. 3c, lane 5) . Therefore, the association of NuMA with snRNPs is specific and sufficiently strong to survive immunoprecipitation. It should be noted that the 160-kDa protein that was observed in Fig. 1 to contain NuMA-like epitopes was not present in any immunocomplex as examined by either [35Sjmethionine labeling or immunoblot analysis. Thus, the 160-kDa appeared not to be associated with snRNP under these experimental conditions.
NuMA Associates with in Vitn-Reconsituted Splicing Complexes. Immunoprecipitation of NuMA by snRNP antibodies suggested that NuMA is associated with snRNPs in interphase nuclei. To address whether NuMA might be a part of the actual splicing apparatus, we turned to in vitro extracts competent for splicing exogenously provided pre-mRNAs (33) . This type of extract is prepared by extracting nuclei in 0.4 M salt and contains both NuMA and multiple snRNPs.
To address the association of NuMA with reconstituted splicing complexes (spliceosomes), we asked whether NuMA antibodies could immunoprecipitate radiolabeled pre-mRNA added to a splicing reaction. A wild-type one-intron premRNA derived from adenovirus was used as the pre-mRNA (16); a similar-length plasmid RNA was used as a negative control RNA. Both RNAs were added to complete splicing reaction mixtures and incubated for 10 min at 30TC. This time interval is sufficient to permit assembly of the first ATPdependent splicing complex but is not sufficient to permit the appearance of splicing intermediates and products. Reaction products were immunoprecipitated with IgG fractions of NuMA antibodies and with the aSm monoclonal antibody Y12. As shown in Fig. 4 , both 2D3 and 8.22 antibodies immunoprecipitated the pre-mRNA, but not the control RNA, as effectively as the anti-snRNP antibody, suggesting that NuMA protein is associated with in vitro-reconstituted spliceosomes.
The results shown here demonstrate a correlation between the nucleoskeleton and the pre-mRNA splicing apparatus. Antibody 8.22, which is generated against a portion of NuMA, may represent a specific group of NuMA antibodies, which stain discrete domains in interphase nuclei. Therefore, some epitopes of NuMA appear to be masked in the nucleus and not recognized by all NuMA antibodies. The following points support our conclusion that the speckle pattern of 8.22 is contributed by a specific form ofNuMA: (i) If, for example, the nuclear speckles represent the 160-kDa protein and not NuMA, 2D3 antibody should stain both a speckle pattern and a diffuse staining pattern, since 2D3 and 8.22 resolve the same 160-kDa band in immunoblots. (ii) In core filament preparations, the 160-kDa protein disappeared from the immunoblots, whereas the fluorescent speckle pattern of 8.22 remained the same as the control cell. (iii) Other NuMA antibodies have been reported to produce a speckle staining pattern (17, 23 8.22 and snRNP antibodies, known as speckles, appear to be actively involved in premRNA processing. Elegant microscopic visualization of cellular RNAs undergoing transcription, processing, and transport indicates that pre-mRNA passes through these snRNPrich speckles as they mature (8) (9) (10) (11) . Our results suggest that the processing centers are attached to the nuclear substructure through a nuclear core filament protein. Such attachment could poise a pre-mRNA for transport via continued association with nuclear filaments.
Anti-NuMA antibodies also detected a biochemical association between NuMA antigens and both nuclear snRNPs and in vitro-reconstituted splicing complexes. Given the filamentous nature of NuMA (21, 22) , it seems unlikely that NuMA plays a functional role in the splicing process. More likely, NuMA is a nuclear structural component involved in association of the splicing apparatus with elements of the nucleoskeleton. Electron microscopic visualization of purified in vitro-reconstituted splicing complexes has revealed the presence of a fibrous extension from a large globular complex that could represent NuMA or a NuMA-like protein (39) . In this light, alternatively spliced NuMA gene products may represent a subset of NuMAs associated specifically with the splicing apparatus.
